Skip to main content
WoMWeb of Medicine
SearchGraphHistory
Community Medicine›Condition·Updated Jul 11, 2026·v1

Electronic Health Record Interoperability

EHR interoperability is a multi-level challenge requiring technical standards (FHIR, OMOP-CDM), terminology mapping, governance, and clinician engagement. The most effective strategies combine hybrid standards, iterative implementation, and policy alignment. Persistent barriers include data quality, semantic gaps, and regulatory conflicts. Achieving meaningful interoperability reduces patient harm, improves care coordination, and enables population health management.

Moderate Evidence59 references·8,684 words·35 min read·v1
electronic health recordinteroperabilityhealth information exchangeFHIRcommunity medicine

Quick Reference

RxDrug of choiceHL7 FHIR (Fast Healthcare Interoperability Resources) - the leading standard for real-time data exchange, used in 39% of implementation studies and adopted by 73% of PCORnet organizations.
AltAlternativesOMOP-CDM for large-scale observational research; openEHR for comprehensive clinical data persistence; HL7 v2/v3 for legacy system integration.
⊘AvoidProprietary interfaces that do not use standard APIs; non-dynamic consent models that cannot be machine-enforced; blockchain systems that cannot comply with GDPR right to erasure (store identifiable data off-chain).
DxTest of choiceHIMSS Interoperability Maturity Model assessment; Terminology mapping audit to measure LOINC/SNOMED CT coverage of local codes.
ScKey scoreInteroperability level (foundational, structural, semantic, organizational); FHIR adoption rate; data completeness score (% of structured fields mapped to standard terminologies).
→When to referWhen integration gaps lead to patient safety incidents (e.g., missing lab results, medication errors); when organizational interoperability fails (e.g., inability to share patient summaries across networks); when implementing a new EHR system with complex data exchange requirements.
EHR interoperability is essential for patient safety and care coordination. The most effective approach combines FHIR for exchange, OMOP-CDM for analytics, strong governance, and clinician engagement. Policy mandates drive adoption, but real-world gaps persist, especially for vulnerable populations, achieving semantic interoperability for all key data types should be the minimum goal.
EHR interoperability is the ability of disparate health information systems to exchange, interpret, and use data without loss of meaning. Without it, patient safety is compromised, care coordination fails, and population health management is impossible. The key to successful interoperability is a hybrid approach combining FHIR for real-time exchange, OMOP-CDM for analytics, and robust governance with clinician engagement. This page provides an overview of essential concepts, clinical importance, and actionable implementation strategies.

Overview and Recommendations

Key Facts

  • •Interoperability exists across four progressive levels, foundational (data transport), structural (format/syntax), semantic (shared meaning), and organizational (governance/workflow). Semantic interoperability is the most critical for clinical use because it ensures that coded data (e.g., diagnoses, lab results) are interpreted identically by all systems.
  • •HL7 FHIR (Fast Healthcare Interoperability Resources) is the leading standard for real-time data exchange, adopted by 39% of implementation studies and 73% of PCORnet organizations in production. However, FHIR often requires customization that paradoxically undermines the very interoperability it aims to achieve.
  • •Terminology mapping gaps remain a major barrier: 718 of 1,173 custom codes for wearable-device data had no equivalents in LOINC or SNOMED CT, and NLP-based LOINC mapping achieves only 42.3% accuracy on noisy datasets. Without consistent coding, semantic interoperability fails.
  • •Poor interoperability directly causes patient harm. At a major hospital go-live, serious radiology-related incidents rose from 1 to 12, with 11 directly attributable to integration gaps. Incomplete medication histories and missing prior test results are common consequences of fragmented systems.
  • •Policy mandates (21st Century Cures Act, European Health Data Space) drive adoption, but real-world ideal data exchange remains low, only 8% of family physicians report ideal interoperability for outside test results. Vulnerable populations are disproportionately affected (OR 0.66 for ideal interoperability).

Clinical Importance

  • •Suspect interoperability failure when clinicians report duplicate testing, missing prior results, or medication errors after care transitions. These are the earliest signs of data fragmentation.
  • •Assess the organization's current interoperability maturity using the HIMSS model: check whether data exchange is at foundational (basic transport), structural (parsed fields), semantic (coded meaning), or organizational (cross-institutional governance) level.
  • •Examine for evidence of incomplete electronic problem lists, these are central to clinical decision support but are often outdated or inconsistently maintained when systems are not interoperable.
  • •Order a terminology mapping audit: what percentage of laboratory codes map to LOINC? What percentage of diagnosis codes map to SNOMED CT? A coverage rate below 90% indicates a risk of semantic interoperability failure.
  • •For medication safety, verify that medication reconciliation is supported across all connected systems with structured data (not free text). Unstructured notes increase the risk of adverse drug events.
  • •For diagnostic accuracy, ensure that prior imaging and lab results from external sources are available in the native EHR. In rural hospitals, interoperable alerts for Staphylococcus aureus bacteremia improved guideline-concordant care.
  • •Measure the proportion of data types exchanged ideally (e.g., 8-19% for outside test results; 19% for encounter documents). Set improvement targets based on national benchmarks.
  • •Evaluate consent management: is dynamic consent supported (granular, revocable patient preferences)? The HL7 FHIR Consent resource provides an interoperable representation, but large-scale deployment remains limited by non-canonical semantics.
  • •Also consider the impact on vulnerable populations: physicians with panels of more than 50% vulnerable patients are significantly less likely to experience ideal interoperability for primary care notes and consultation reports (OR 0.66).
  • •For population health, check whether patient-reported outcomes (ePROs) can be integrated into workflows. Interoperable ePRO systems reduce emergency visits and hospitalizations, but they require structured data exchange across platforms.

Implementation Strategies

  • •Adopt a hybrid standards approach: use FHIR for real-time clinical exchange, OMOP-CDM for large-scale analytics, and openEHR for comprehensive clinical data persistence. No single standard serves all use cases.
  • •Implement FHIR-enabled RESTful APIs for bidirectional data exchange; ensure they are vendor-agnostic to allow third-party services (e.g., pharmacogenomic guidance) to integrate without custom interfaces.
  • •Establish governance: assign clear ownership for data quality and problem list accuracy. Incomplete problem lists undermine clinical decision support and interoperability. Use clinician-led workflows with NLP/ML support for curation.
  • •Invest in terminology mapping using complementary algorithms, deploy a hybrid pipeline that combines NLP-based mapping (e.g., ScispaCy-LOINC) with semantic search. This handles the variable data quality across real-world datasets.
  • •Train clinicians on EHR workflows to reduce inbox burden and alert fatigue. Family physicians spend ~50% of professional time on indirect patient care activities; fragmented systems worsen burnout and lead to uninformed decisions.
  • •Integrate smart infusion pumps with EHRs for bidirectional interoperability. All 7 US studies showed positive effects (reduced medication errors, improved workflow efficiency), but evidence quality is low; prioritize controlled designs.
  • •For blockchain, consider only for specific use cases like immutable audit trails or automated trial matching (6000 simulated patients matched in 2.13 seconds). Beware of GDPR conflicts: right to erasure vs. immutability. Store identifiable data off-chain.
  • •Monitor interoperability outcomes: exchange success rates, API response times, data completeness (target >90% of structured fields mapped to standard terminologies). Regular audits of problem list accuracy maintain trust.
  • •Ensure compliance with regulatory mandates: 21st Century Cures Act (TEFCA, Individual Access Service), European Health Data Space (ICF integration), and GDPR (dynamic consent, privacy-by-design).
  • •For population health, integrate patient-reported outcomes (ePROs) via FHIR. This improves symptom control and quality of life while reducing emergency visits. Start with a single domain (e.g., oncology) and scale.
  • •Avoid proprietary interfaces that lock data into a single vendor. Insist on FHIR-native APIs for all new EHR purchases. Vendor-agnostic design is the single most important technical decision for long-term interoperability.
  • •Refer to health IT specialists when integration gaps cause patient safety incidents (e.g., missing lab results, medication errors). Establish a rapid response team for go-live transitions to prevent serious incidents.
  • •When implementing a new EHR, perform end-to-end testing across all interfaces before go-live. The Helsinki Radiant go-live showed that incomplete integration testing is the most common cause of post-implementation safety events.
  • •Use the HIMSS Interoperability Maturity Model to guide progressive improvement. Set a goal to achieve at least structural interoperability for all data types within 12 months, and semantic interoperability for high-priority data (medications, allergies, problems) within 24 months.
  • •Discharge criteria for a successful interoperability implementation: >90% of laboratory results and medications mapped to standard terminologies, <5% of clinical decisions affected by missing data, and clinician satisfaction scores >70% on data availability.

Board Review — High Yield

  • •Four levels of interoperability, Foundational, structural, semantic, organizational. Semantic is the most critical for clinical decision support because it ensures shared meaning of coded data.
  • •FHIR adoption, Used in 39% of implementation studies; 73% of PCORnet organizations have FHIR in production, but data quality varies (Cohen kappa 0.01-0.76 for diagnoses).
  • •Data quality issues, 68% of completeness issues induced by FHIR transformation are resolvable; dedicated data quality assessments are essential.
  • •LOINC mapping, NLP-based mapping achieves 42.3% accuracy on noisy data (MIMIC-IV) vs. 54.4% for semantic search on cleaner data (CIEL). Hybrid approaches are recommended.
  • •Patient safety, Go-live of a new EHR increased serious radiology incidents from 1 to 12 due to integration gaps; 11 were directly attributable to failures of organizational interoperability.
  • •Terminology gaps, 718 of 1,173 custom codes for wearable device data had no LOINC/SNOMED CT equivalents; heart rate variability metrics like RMSSD and pNN50 remain uncoded.
  • •Consent management, Dynamic consent is patient-centered but faces barriers: cost, digital divide, and conflicts with blockchain immutability. The HL7 FHIR Consent resource provides a machine-readable representation.
  • •Blockchain challenges, Right to erasure vs. immutability is a key unresolved conflict. Most blockchain implementations are non-production prototypes.
  • •UAE case, 75% EHR penetration in Dubai private clinics, yet limited cross-Emirate interoperability remains a persistent barrier. Nationwide adoption does not guarantee cross-facility exchange.
  • •EHDS, Mandates ICF for functioning data, but most EU countries lack standardized EHR support. A three-phase roadmap (awareness, FHIR integration, policy alignment) is proposed for 2030.

Deep Dive — Evidence Details

References

  1. [1]

    Sheikh Z, Samarth G, Jaffer U. “Blockchain Smart Contracts for Automating Clinical Trials: Systematic Review and Proposed System Architecture.” JMIR medical informatics (2026). PMID: 42207982 ↗

    L5TRIAL_NONRANDOMCited in: Introduction and Definition, Challenges and Barriers, Implementation Strategies and Best Practices, Security and Privacy Considerations, Future Directions and Emerging Technologies
  2. [2]

    Nair R, Bekker I, Singer A et al.. “Current state of electronic problems lists in primary care: a rapid scoping review.” Family practice (2026). PMID: 42275183 ↗

    L2REVIEW_NARRATIVECited in: Introduction and Definition, Clinical Importance and Benefits, Challenges and Barriers, Implementation Strategies and Best Practices, Future Directions and Emerging Technologies
  3. [3]

    von Arnim G, Kohler S, Hegselmann S et al.. “Rethinking healthcare data interoperability in the age of large language models.” Med (New York, N.Y.) (2026). PMID: 42208539 ↗

    L5REVIEW_NARRATIVECited in: Introduction and Definition, Challenges and Barriers
  4. [4]

    Pokharel A, Kathayat S. “Blockchain-Enabled Self-Sovereign Identity Applications in Health Care: Scoping Review.” Journal of medical Internet research (2026). PMID: 42190234 ↗

    L2REVIEW_NARRATIVECited in: Introduction and Definition, Levels of Interoperability, Challenges and Barriers, Implementation Strategies and Best Practices, Security and Privacy Considerations, Future Directions and Emerging Technologies
  5. [5]

    Haynes E, Brannigan J, Suna J et al.. “Exploring Technological Solutions for Interoperability Between Patient Electronic Medical Records and Clinical Registries: Scoping Review.” Journal of medical Internet research (2026). PMID: 42184342 ↗

    L2REVIEW_NARRATIVECited in: Introduction and Definition, Future Directions and Emerging Technologies
  6. [6]

    Phuyal S, Bhandari M, Correia Bezerra R et al.. “Dynamic Consent for Secondary Use of Health Data: Challenges and Opportunities Under European Law.” JMIR medical informatics (2026). PMID: 42304949 ↗

    L5REVIEW_NARRATIVECited in: Introduction and Definition, Security and Privacy Considerations
  7. [7]

    Eryılmaz B, Arzideh K, Bahn M et al.. “Extracting Medical Information From Unstructured Clinical Text Using Large Language Models to Enhance Health Care Interoperability: Proof-of-Concept Study.” Journal of medical Internet research (2026). PMID: 42390385 ↗

    L4OTHERCited in: Introduction and Definition, Key Standards and Frameworks
  8. [8]

    Jämsä J, Tissari P, Kovanen J et al.. “Patient safety concerns in the go-live phase of an electronic health record implementation.” International journal of medical informatics (2026). PMID: 42296876 ↗

    L2OTHERCited in: Introduction and Definition, Clinical Importance and Benefits, Levels of Interoperability
  9. [9]

    Rudin RS, Chhatiawala N, Mandel JC et al.. “Approaches to Collect Comprehensive Electronic Patient Data Across Multiple Providers and Payers for Research: Landscape Analysis.” Journal of medical Internet research (2026). PMID: 42296529 ↗

    L5OTHERCited in: Introduction and Definition, Regulatory and Policy Environment
  10. [10]

    Lourenço Santos R, Cruz-Correia RJ. “An HL7 FHIR® IG for lifestyle medicine in learning health systems: Multi-vendor wearable interoperability with documented terminology gaps.” International journal of medical informatics (2026). PMID: 42176600 ↗

    L4OTHERCited in: Introduction and Definition, Key Standards and Frameworks
  11. [11]

    Scholes AK, Elma A, Cernat A et al.. “Family physician perspectives on managing indirect patient care activities in the electronic inbox: a systematic mixed studies review.” Family practice (2025). PMID: 41269285 ↗

    L2SR_OBSCited in: Clinical Importance and Benefits, Challenges and Barriers, Global Perspectives and Case Studies
  12. [12]

    Emamekhoo H, Riaz IB, Martin DB et al.. “Deriving wisdom from data: The value and continued rationale for structured data in the era of artificial intelligence-driven oncology care.” Cancer (2026). PMID: 41701629 ↗

    L5REVIEW_NARRATIVECited in: Clinical Importance and Benefits
  13. [13]

    Shen Y, Yu J, Zhou J et al.. “Twenty-Five Years of Evolution and Hurdles in Electronic Health Records and Interoperability in Medical Research: Comprehensive Review.” Journal of medical Internet research (2025). PMID: 39787599 ↗

    L5REVIEW_NARRATIVECited in: Clinical Importance and Benefits
  14. [14]

    Torab-Miandoab A, Basiri M, Dabbagh-Moghaddam A et al.. “Electronic health record in military healthcare systems: A systematic review.” PloS one (2025). PMID: 39937758 ↗

    L2SR_OBSCited in: Clinical Importance and Benefits
  15. [15]

    Gomes Siqueira LBM, Callens D, Choi S et al.. “Implementation of electronic patient-reported outcomes in supportive care for oncology patients.” Current opinion in supportive and palliative care (2026). PMID: 41549860 ↗

    L5REVIEW_NARRATIVECited in: Clinical Importance and Benefits, Levels of Interoperability
  16. [16]

    Albanyan N, Alrashed AA, Howaidi J et al.. “Integration of electronic health records with automated compounding for parenteral nutrition: A narrative review.” JPEN. Journal of parenteral and enteral nutrition (2026). PMID: 41492136 ↗

    L5REVIEW_NARRATIVECited in: Clinical Importance and Benefits
  17. [17]

    Strasberg HR, Hoffer EP, Koppel R et al.. “Opportunities for informatics to improve patient experiences: observations and reflections of ACMI fellows.” Journal of the American Medical Informatics Association : JAMIA (2026). PMID: 41979031 ↗

    L5OTHERCited in: Clinical Importance and Benefits
  18. [18]

    Keating JA, Legenza L, McKinley L et al.. “Tailoring clinical decision support for rural hospitals: A qualitative pilot study of accessing infectious disease expertise for Staphylococcus aureus bacteremia.” American journal of infection control (2025). PMID: 41421794 ↗

    L4OTHERCited in: Clinical Importance and Benefits
  19. [19]

    Chandak A, Chandak P, Soni N. “Blockchain applications in electronic health records: a systematic review of qualitative and quantitative evidence.” BMC medical informatics and decision making (2026). PMID: 41943148 ↗

    L2SR_OBSCited in: Key Standards and Frameworks, Challenges and Barriers, Implementation Strategies and Best Practices, Security and Privacy Considerations, Future Directions and Emerging Technologies, Global Perspectives and Case Studies
  20. [20]

    Marfoglia A, Arcobelli VA, Moscato S et al.. “Challenges of health data standard adoption and usage: a systematic review.” Journal of biomedical informatics (2026). PMID: 41871756 ↗

    L2SR_OBSCited in: Key Standards and Frameworks, Challenges and Barriers, Implementation Strategies and Best Practices
  21. [21]

    Finster M, Wenzel M, Taghizadeh E. “Common data models and data standards for tabular health data: a systematic review.” BMC medical informatics and decision making (2025). PMID: 41233809 ↗

    L2SR_OBSCited in: Key Standards and Frameworks, Global Perspectives and Case Studies
  22. [22]

    Nieminen L, Anttila H, Ketamo H et al.. “A call for action to strengthen stakeholder readiness for ICF data exchange in European health data space: a structured narrative review.” Frontiers in public health (2026). PMID: 42088236 ↗

    L5REVIEW_NARRATIVECited in: Key Standards and Frameworks, Technical Infrastructure and Architectures, Regulatory and Policy Environment, Global Perspectives and Case Studies
  23. [23]

    Hoang MT, Donnelly C, Igasto C et al.. “Data-Driven Guideline Adherence in Data Representation and Compliance Measurement: Scoping Review.” Journal of medical Internet research (2026). PMID: 41662662 ↗

    L2REVIEW_NARRATIVECited in: Key Standards and Frameworks
  24. [24]

    Duranteau O, Popoff B. “Data integration and systems interoperability: the prerequisite for artificial intelligence in anesthesiology.” Current opinion in anaesthesiology (2026). PMID: 41684268 ↗

    L5REVIEW_NARRATIVECited in: Key Standards and Frameworks
  25. [25]

    Ungurean I, Gherman OI, Lavric A et al.. “A privacy-centric microservice framework for secure FHIR-based integration of heterogeneous medical data.” International journal of medical informatics (2026). PMID: 42114371 ↗

    L4OTHERCited in: Key Standards and Frameworks
  26. [26]

    Phuyal S, Bhandari M, Bista R et al.. “HL7 FHIR consent for healthcare data sharing: challenges, opportunities and integrity implications.” International journal of medical informatics (2026). PMID: 41905015 ↗

    L5OTHERCited in: Key Standards and Frameworks
  27. [27]

    Tcheng JE, Finney D, Boone K et al.. “Evaluating the potential of fast healthcare interoperability resources for clinical registry data submission.” Journal of the American Medical Informatics Association : JAMIA (2026). PMID: 41801964 ↗

    L5OTHERCited in: Key Standards and Frameworks
  28. [28]

    Tahar K, Verbuecheln R, Martin T et al.. “Sharing EHR data of patients with rare diseases for research - The role of quality assessments in a national federated research data infrastructure.” BMC medical informatics and decision making (2026). PMID: 41772550 ↗

    L5OTHERCited in: Key Standards and Frameworks
  29. [29]

    Grau L, Urrunaga J, Santisteban J. “WiraChain: a blockchain and FHIR-based platform for improving clinical data interoperability in healthcare.” Frontiers in public health (2026). PMID: 41743481 ↗

    L5OTHERCited in: Key Standards and Frameworks
  30. [30]

    Naliyatthaliyazchayil P, Sangam VR, Amlung J et al.. “Automated Logical Observation Identifiers Names and Codes mapping with biomedical natural language processing models: enabling scalable health information exchange via the Open Concept Lab.” Journal of the American Medical Informatics Association : JAMIA (2026). PMID: 41671017 ↗

    L5OTHERCited in: Key Standards and Frameworks, Technical Infrastructure and Architectures
  31. [31]

    Marsolo K, Louzao D, Hart K et al.. “Investigating the Use of the Fast Health Care Interoperability Resources (FHIR) Standard to Support Data Activities Across the PCORnet® Infrastructure: Lessons Learned From the FHIR Pilots of the Coordinating Center for PCORnet®.” Medical care (2026). PMID: 41504752 ↗

    L5OTHERCited in: Key Standards and Frameworks
  32. [32]

    Golburean O, Nordheim ES, Faxvaag A et al.. “A systematic review and proposed framework for sustainable learning healthcare systems.” International journal of medical informatics (2024). PMID: 39423652 ↗

    L5SR_OBSCited in: Technical Infrastructure and Architectures
  33. [33]

    Lum B, Weerasinghe N, Chu CH et al.. “Examining implementation outcomes in health information exchange systems: A scoping review.” Journal of biomedical informatics (2025). PMID: 39842684 ↗

    L5REVIEW_NARRATIVECited in: Technical Infrastructure and Architectures
  34. [34]

    Adler-Milstein J, Linden A, Hsia RY et al.. “Electronic connectivity between hospital pairs: impact on emergency department-related utilization.” Journal of the American Medical Informatics Association : JAMIA (2025). PMID: 41252584 ↗

    L2OTHERCited in: Technical Infrastructure and Architectures
  35. [35]

    Idrissi-Yaghir A, Arzideh K, Schäfer H et al.. “Using a Diverse Test Suite to Assess Large Language Models on Fast Health Care Interoperability Resources Knowledge: Comparative Analysis.” Journal of medical Internet research (2025). PMID: 40795315 ↗

    L5OTHERCited in: Technical Infrastructure and Architectures
  36. [36]

    He L, Rao S, Tian K et al.. “A Post-Quantum Blockchain and Autonomous AI-Enabled Scheme for Secure Healthcare Information Exchange.” IEEE journal of biomedical and health informatics (2025). PMID: 40512643 ↗

    L5OTHERCited in: Technical Infrastructure and Architectures
  37. [37]

    Sharma V, McDermott J, Keen J et al.. “Designing an interoperable solution to support pharmacogenomic-guided prescribing in primary care: an implementer report.” BMJ health & care informatics (2025). PMID: 40216452 ↗

    L5OTHERCited in: Technical Infrastructure and Architectures
  38. [38]

    Kobayashi S, Kimura M, Kodama Y et al.. “Development of Japan-Specific HL7 FHIR Medication-Related Profiles.” Journal of medical systems (2025). PMID: 40199759 ↗

    L5OTHERCited in: Technical Infrastructure and Architectures
  39. [39]

    Sandhu S, Liu M, Gottlieb LM et al.. “Interoperability of health-related social needs data at US hospitals.” Journal of the American Medical Informatics Association : JAMIA (2025). PMID: 40116928 ↗

    L2OTHERCited in: Technical Infrastructure and Architectures
  40. [40]

    Svetlanova S, Karibayeva I, Aliyeva S et al.. “Mapping the landscape of AI in healthcare in Kazakhstan: a scoping review of readiness, development, and adoption.” BMC health services research (2026). PMID: 41935295 ↗

    L5SR_OBSCited in: Levels of Interoperability, Implementation Strategies and Best Practices, Future Directions and Emerging Technologies
  41. [41]

    Wu Y, Ren M, Chen N et al.. “Semantics-driven improvements in electronic health records data quality: a systematic review.” BMC medical informatics and decision making (2025). PMID: 40790196 ↗

    L5SR_OBSCited in: Levels of Interoperability
  42. [42]

    Amar F, April A, Abran A. “Electronic Health Record and Semantic Issues Using Fast Healthcare Interoperability Resources: Systematic Mapping Review.” Journal of medical Internet research (2024). PMID: 38289660 ↗

    L5SR_OBSCited in: Levels of Interoperability
  43. [43]

    Schmidt BM, Colvin CJ, Hohlfeld A et al.. “Definitions, components and processes of data harmonisation in healthcare: a scoping review.” BMC medical informatics and decision making (2020). PMID: 32928214 ↗

    L5REVIEW_NARRATIVECited in: Levels of Interoperability
  44. [44]

    Alfakhri A, Almadani O, Asiri I et al.. “Evaluating the Readiness of Saudi Oncology Real-World Data for Standardization and Quality Enhancement.” JCO clinical cancer informatics (2026). PMID: 41632525 ↗

    L4OTHERCited in: Levels of Interoperability
  45. [45]

    Gu Y, Koornneef E, Alnaqbi KA. “Healthcare reforms in the United Arab Emirates from 2017 to 2024: A systematic review on progress and strategic priorities.” Health policy (Amsterdam, Netherlands) (2026). PMID: 42035684 ↗

    L2SR_OBSCited in: Challenges and Barriers, Implementation Strategies and Best Practices, Regulatory and Policy Environment, Global Perspectives and Case Studies
  46. [46]

    Sallam S, Cebulla A, Brommeyer M et al.. “Unlocking the potential of clinical decision support in cardiovascular care: A mixed-methods systematic review of implementation barriers and enablers.” International journal of medical informatics (2026). PMID: 41921371 ↗

    L2SR_OBSCited in: Challenges and Barriers, Implementation Strategies and Best Practices
  47. [47]

    Taylor LC, Peek N, Ercole A et al.. “Enabling digital multifactorial risk assessment in primary care: an umbrella review and recommendations for design and implementation.” BMJ health & care informatics (2026). PMID: 41775410 ↗

    L2SR_OBSCited in: Challenges and Barriers, Implementation Strategies and Best Practices, Future Directions and Emerging Technologies
  48. [48]

    Kuitunen S, Alves BL, Peitsoma H et al.. “Effects of a bidirectional interoperability between electronic health records and smart infusion pumps in hospital settings: a systematic review.” BMJ health & care informatics (2026). PMID: 41781036 ↗

    L2SR_OBSCited in: Implementation Strategies and Best Practices, Future Directions and Emerging Technologies
  49. [49]

    Wilson K, Khansa L. “Migrating to electronic health record systems: A comparative study between the United States and the United Kingdom.” Health policy (Amsterdam, Netherlands) (2018). PMID: 30193980 ↗

    L5REVIEW_NARRATIVECited in: Regulatory and Policy Environment
  50. [50]

    Tonner C, Schmajuk G, Yazdany J. “A new era of quality measurement in rheumatology: electronic clinical quality measures and national registries.” Current opinion in rheumatology (2017). PMID: 27941392 ↗

    L5REVIEW_NARRATIVECited in: Regulatory and Policy Environment
  51. [51]

    Everson J, Adler-Milstein J, Phillips RL et al.. “EHR Interoperability Experiences Reported by Family Physicians.” JAMA network open (2025). PMID: 41231471 ↗

    L4OTHERCited in: Regulatory and Policy Environment
  52. [52]

    Jain P, Jain B, Doshi R et al.. “Digital Health: An Opportunity to Advance Health Equity for People With Disabilities.” The Milbank quarterly (2025). PMID: 40876870 ↗

    L5OTHERCited in: Regulatory and Policy Environment
  53. [53]

    Newton TJ, Shah N, Lewis K et al.. “Developing Infrastructure to Realize the Value of Patient-Generated Health Data in a Large Integrated Health Care System: The Veterans Health Administration Experience.” Journal of medical Internet research (2025). PMID: 40479588 ↗

    L4OTHERCited in: Regulatory and Policy Environment
  54. [54]

    Pfitzer E, Bitomsky L, Nißen M et al.. “Success Factors of Growth-Stage Digital Health Companies: Systematic Literature Review.” Journal of medical Internet research (2024). PMID: 39661978 ↗

    L5SR_OBSCited in: Security and Privacy Considerations, Global Perspectives and Case Studies
  55. [55]

    Singh Y, Jabbar MA, Kumar Shandilya S et al.. “Exploring applications of blockchain in healthcare: road map and future directions.” Frontiers in public health (2023). PMID: 37790716 ↗

    L5SR_OBSCited in: Security and Privacy Considerations
  56. [56]

    İşcan G, Çöme O. “Security and privacy in e-health technologies: a scoping review of challenges and strategies in primary care.” Family practice (2026). PMID: 41736688 ↗

    L5REVIEW_NARRATIVECited in: Security and Privacy Considerations
  57. [57]

    Hallinan CM, Ward R, Hart GK et al.. “Seamless EMR data access: Integrated governance, digital health and the OMOP-CDM.” BMJ health & care informatics (2024). PMID: 38387992 ↗

    L5REVIEW_NARRATIVECited in: Security and Privacy Considerations
  58. [58]

    Lambarth A, Wainwright D, Saha T et al.. “Electronic medicine management systems in developing countries: A landscape review.” British journal of clinical pharmacology (2025). PMID: 40592719 ↗

    L2SR_OBSCited in: Global Perspectives and Case Studies
  59. [59]

    Deng T, Xue Y, Methakanjanasak N. “Digital health integration in chronic kidney disease.” Clinica chimica acta; international journal of clinical chemistry (2025). PMID: 41319907 ↗

    L5REVIEW_NARRATIVECited in: Global Perspectives and Case Studies

Revision History

All updates applied to this page

Loading revisions…